Bioimplants Market by Type, Material - Global Opportunity Analysis and Industry Forecast, 2017-2023

DESCRIPTION
TABLE OF CONTENTS
SUMMARY
FORMATS / FAQ

1 of 4

Bioimplant are medical devices or tissues that are surgically transplanted inside the body. These implants are used to replace or support any damaged body organs to enhance function of any body organ or to detect errors in normal body functioning. These can be either placed permanently or temporarily in human body and can be removed when they are no longer needed. Some of the implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other materials.

The global bioimplant market was evaluated at $77,738 million in 2016, and is estimated to reach $124,154 million by 2023, with a CAGR of 6.9% during the forecast period. The growth in the bioimplant market is primarily attributed to the rise in prevalence of chronic diseases coupled with the rapidly aging population. Moreover, increased awareness and technological advancements in bioimplant further support the growth of the market. However, high implantation cost and lack of expertise are some of the factors that restrain the growth of the bioimplant market.

The global bioimplant market is segmented based on product type, material, and region. Based on product type, the market is categorized into cardiovascular implant, dental implant, orthopedic implant, spinal implant, ophthalmic implant, and others. By Material Type, it is divided into metallic biomaterial, ceramic biomaterial, polymer biomaterial, and natural biomaterials. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report provides an extensive analysis of the current and emerging trends and dynamics in the global bioimplants market to identify the prevailing opportunities.
It presents a competitive landscape of the global market to predict the competitive environment across geographies.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Region- and country-wise analyses are provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS

By Type

Cardiovascular bioimplant
Stent
Coronary stent
Drug-eluting stent (DES)
Bare-metal coronary stent
Bioabsorbable stent
Peripheral stent
Iliac
Femoral-popliteal
Renal
Carotid
Stent-related bioimplant
Synthetic graft
Vena Cava filter
Pacing device
Cardiac resynchronization therapy device (CRTs)
Implantable cardioverter defibrillator (ICDs)
Implantable cardiac pacemaker (ICPs)
Structural Cardiac Implant
Mechanical heart valve
Implantable ventricular-assist device
Dental bioimplant
Plate form dental implant
Root form dental implant
Orthopedic bioimplant
Reconstructive joint replacement
Knee replacement implant
Hip replacement implant
Extremities
Orthobiologics
Trauma & craniomaxillofacial
Spinal bioimplant
Spinal fusion implant
Spinal bone stimulator
Vertebral compression fracture (VCF) device
Motion preservation devices/non-fusion device
Spine biologics
Ophthalmology bioimplant
Glaucoma implant
Intraocular implant
Others

By material

Metallic biomaterial
Ceramic biomaterial
Polymers biomaterial
Natural biomaterial

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

The key players profiled in this report are as follows:

Abbott Laboratories (St. Jude Medical, Inc.)
Boston Scientific Corporation
Dentsply Sirona Inc.
Johnson & Johnson (Ethicon, Inc.)
Medtronic plc
Smith & Nephew plc
Stryker Corporation
Victrex Plc. (Invibio Ltd.)
Wright Medical Group N.V.
Zimmer Biomet Holdings Inc.

The other players in the value chain include (*These players have not been profiled in the report, but can be included on request.):

GC Aesthetics plc
Allergan Inc.
Sientra Inc.
Danaher Corporation
3M Company
Polytech Health & Aesthetics GmbH
B. Braun Melsungen AG
Elixir Medical Corporation
Microport Scientific Corporation
STENTYS S.A.
Terumo Corporation

Note: Product cover images may vary from those shown

2 of 4

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. Top player positioning, 2016
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Growth in elderly population and rise in prevalence of chronic diseases
3.4.1.2. Technological advancements in the field of bioimplant
3.4.1.3. Global rise in acceptance of bioimplant
3.4.1.4. Better insurance and reimbursement
3.4.1.5. Increase in government focus on funding R&D initiatives
3.4.2. Restraints
3.4.2.1. High cost of treatment associated with bioimplant
3.4.2.2. Stringent approval process
3.4.3. Opportunities
3.4.3.1. Huge market opportunities in the APAC region and developing countries
3.4.3.2. Increase in development of minimally invasive and non-surgical procedures
3.4.3.3. Rise in awareness amongst patients and increasing preference for a better quality of life
3.4.4. Impact analysis

CHAPTER 4: BIOIMPLANT MARKET BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Cardiovascular implant
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by type
4.2.3. Stent
4.2.3.1. Market size and forecast
4.2.3.2. Coronary stent
4.2.3.2.1. Market size and forecast
4.2.3.2.2. Drug-eluting stent
4.2.3.2.2.1. Market size and forecast
4.2.3.2.3. Bare-metal coronary stent
4.2.3.2.3.1. Market size and forecast
4.2.3.2.4. Bioabsorbable stent
4.2.3.2.4.1. Market size and forecast
4.2.3.3. Peripheral stent
4.2.3.3.1. Market size and forecast
4.2.3.3.2. Iliac stent
4.2.3.3.2.1. Market size and forecast
4.2.3.3.3. Femoral-popliteal stent
4.2.3.3.3.1. Market size and forecast
4.2.3.3.4. Renal stent
4.2.3.3.4.1. Market size and forecast
4.2.3.3.5. Carotid stent
4.2.3.3.5.1. Market size and forecast
4.2.3.4. Stent-related implant
4.2.3.4.1. Market size and forecast
4.2.3.4.2. Synthetic graft
4.2.3.4.2.1. Market size and forecast
4.2.3.4.3. Vena cava filter
4.2.3.4.3.1. Market size and forecast
4.2.4. Pacing device
4.2.4.1. Market size and forecast
4.2.4.2. Cardiac resynchronisation therapy (CRT)
4.2.4.2.1. Market size and forecast
4.2.4.3. Implantable cardioverter defibrillators (ICDs)
4.2.4.3.1. Market size and forecast
4.2.4.4. Implantable cardiac pacemaker (ICP)
4.2.4.4.1. Market size and forecast
4.2.5. Structural cardiac implant
4.2.5.1. Market size and forecast
4.2.5.2. Mechanical heart valve
4.2.5.2.1. Market size and forecast
4.2.5.3. Implantable ventricular-assist device (VAD)
4.2.5.3.1. Market size and forecast
4.2.6. Market size and forecast, by region
4.2.7. Market analysis, by country
4.3. Dental and prosthetic implant
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Plate form dental implants
4.3.2.1.1. Market size and forecast
4.3.2.2. Root form dental implants
4.3.2.2.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country
4.4. Orthopedic implant
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Reconstructive joint replacements
4.4.2.1.1. Market size and forecast
4.4.2.1.2. Knee replacement implants
4.4.2.1.2.1. Market size and forecast
4.4.2.1.3. Hip replacement implants
4.4.2.1.3.1. Market size and forecast
4.4.2.1.4. Extremities
4.4.2.1.4.1. Market size and forecast
4.4.2.2. Orthobiologics
4.4.2.2.1. Market size and forecast
4.4.2.3. Trauma & craniomaxillofacial
4.4.2.3.1. Market size and forecast
4.4.3. Market size and forecast, by region
4.4.4. Market analysis, by country
4.5. Ophthalmic implants
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by type
4.5.2.1. Intraocular lens
4.5.2.1.1. Market size and forecast
4.5.2.2. Glaucoma implant
4.5.2.2.1. Market size and forecast
4.5.3. Market size and forecast, by region
4.5.4. Market analysis, by country
4.6. Spinal implants
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by type
4.6.2.1. Spinal fusion devices
4.6.2.1.1. Market size and forecast
4.6.2.2. Motion preservation device
4.6.2.2.1. Market size and forecast
4.6.2.3. Vertebral compression fracture (VCF) devices
4.6.2.3.1. Market size and forecast
4.6.2.4. Spinal bone stimulators
4.6.2.4.1. Market size and forecast
4.6.2.5. Spine biologics
4.6.2.5.1. Market size and forecast
4.6.3. Market size and forecast, by region
4.6.4. Market analysis, by country
4.7. Other implants
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country

CHAPTER 5: BIOIMPLANT MARKET, BY MATERIAL
5.1. Overview
5.1.1. Market size and forecast
5.2. Metallic Biomaterials
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Ceramic Biomaterial
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Polymer Biomaterial
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Natural Biomaterials
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

CHAPTER 6: BIOIMPLANT MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America market size and forecast, by country
6.2.2.1. U.S. bioimplant market size and forecast
6.2.2.1.1. U.S. bioimplant market size and forecast, by product
6.2.2.1.2. U.S. bioimplant market size and forecast, by material
6.2.2.2. Canada bioimplant market size and forecast
6.2.2.2.1. Canada bioimplant market size and forecast, by product
6.2.2.2.2. Canada bioimplant market size and forecast, by material
6.2.2.3. Mexico bioimplant market size and forecast
6.2.2.3.1. Mexico bioimplant market size and forecast, by product
6.2.2.3.2. Mexico bioimplant market size and forecast, by material
6.2.3. North America market size and forecast, by product
6.2.4. North America market size and forecast, by material
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Europe market size and forecast, by country
6.3.2.1. Germany bioimplant market size and forecast
6.3.2.1.1. Germany bioimplant market size and forecast, by product
6.3.2.1.2. Germany bioimplant market size and forecast, by material
6.3.2.2. France bioimplant market size and forecast
6.3.2.2.1. France bioimplant market size and forecast, by product
6.3.2.2.2. France bioimplant market size and forecast, by material
6.3.2.3. UK bioimplant market size and forecast
6.3.2.3.1. UK bioimplant market size and forecast, by product
6.3.2.3.2. UK bioimplant market size and forecast, by material
6.3.2.4. Italy bioimplant market size and forecast
6.3.2.4.1. Italy bioimplant market size and forecast, by product
6.3.2.4.2. Italy bioimplant market size and forecast, by material
6.3.2.5. Spain bioimplant market size and forecast
6.3.2.5.1. Spain bioimplant market size and forecast, by product
6.3.2.5.2. Spain bioimplant market size and forecast, by material
6.3.2.6. Rest of Europe bioimplant market size and forecast
6.3.2.6.1. Rest of Europe bioimplant market size and forecast, by product
6.3.2.6.2. Rest of Europe bioimplant market size and forecast, by material
6.3.3. Europe market size and forecast, by product
6.3.4. Europe market size and forecast, by material
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Asia-Pacific market size and forecast, by country
6.4.2.1. Japan bioimplant market size and forecast
6.4.2.1.1. Japan bioimplant market size and forecast, by product
6.4.2.1.2. Japan bioimplant market size and forecast, by material
6.4.2.2. China bioimplant market size and forecast
6.4.2.2.1. China bioimplant market size and forecast, by product
6.4.2.2.2. China bioimplant market size and forecast, by material
6.4.2.3. India bioimplant market size and forecast
6.4.2.3.1. India bioimplant market size and forecast, by product
6.4.2.3.2. India bioimplant market size and forecast, by material
6.4.2.4. Australia bioimplant market size and forecast
6.4.2.4.1. Australia bioimplant market size and forecast, by product
6.4.2.4.2. Australia bioimplant market size and forecast, by material
6.4.2.5. Rest of Asia-Pacific bioimplant market size and forecast
6.4.2.5.1. Rest of Asia-Pacific bioimplant market size and forecast, by product
6.4.2.5.2. Rest of Asia-Pacific bioimplant market size and forecast, by material
6.4.3. Asia-Pacific market size and forecast, by product
6.4.4. Asia-Pacific market size and forecast, by material
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. LAMEA market size and forecast, by country
6.5.2.1. Brazil bioimplant market size and forecast
6.5.2.1.1. Brazil bioimplant market size and forecast, by product
6.5.2.1.2. Brazil bioimplant market size and forecast, by material
6.5.2.2. South Africa bioimplant market size and forecast
6.5.2.2.1. South Africa bioimplant market size and forecast, by product
6.5.2.2.2. South Africa bioimplant market size and forecast, by material
6.5.2.3. Saudi Arabia bioimplant market size and forecast
6.5.2.3.1. Saudi Arabia bioimplant market size and forecast, by product
6.5.2.3.2. Saudi Arabia bioimplant market size and forecast, by material
6.5.2.4. Rest of LAMEA bioimplant market size and forecast
6.5.2.4.1. Rest of LAMEA bioimplant market size and forecast, by product
6.5.2.4.2. Rest of LAMEA bioimplant market size and forecast, by material
6.5.3. LAMEA market size and forecast, by product
6.5.4. LAMEA market size and forecast, by material

CHAPTER 7: COMPANY PROFILES
7.1. Abbott Laboratories (St. Jude Medical, Inc.)
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. Boston Scientific Corporation
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Dentsply Sirona Inc.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Johnson & Johnson (Ethicon, Inc.)
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. Medtronic plc
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Smith & Nephew plc
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Stryker Corporation
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Victrex Plc. (Invibio Ltd.)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Wright Medical Group N.V.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. Zimmer Biomet Holdings Inc.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

Note: Product cover images may vary from those shown

3 of 4

LOADING...

4 of 4

According to a new report titled, "Bioimplants Market by Type, and Material: Global Opportunity Analysis and Industry Forecast, 2017-2023" the market was valued at $77,738 million in 2016, and is estimated to reach $124,154 million by 2023, with a CAGR of 6.9% during the forecast period.

Bioimplant are devices of human or animal origin used to replace a missing natural body structure, support an injured biological part, or improve an existing biological structure. The major factors that contribute to the market growth include increase in geriatric population, rapid technological advancements, rise in incidence of chronic diseases, surge in adoption of advanced treatment devices, and growth in awareness regarding both the disease and treatment devices available in the market. However, the stringent approval procedure of the bioimplant is expected to impede the market growth. In addition, significant unmet need in the emerging nations provides a lucrative opportunity for the market.

The orthopedic bioimplant segment generated the maximum revenue, accounting for nearly 40% of the global digital bioimplant market in 2016. On the other hand, dental bioimplant segment is expected to witness the highest CAGR during the forecast period.

By material, the metallic biomaterial segment is expected to dominate the market, accounting for nearly two-thirds share in 2023. On the other hand, the polymeric biomaterials segment is estimated to register the highest CAGR during the forecast period.

Key findings of the Bioimplants Market:

The cardiovascular bioimplant segment contributed for nearly one-fourth share of the global bioimplant market in 2016.
The spinal bioimplant segment is projected to grow at a significant CAGR from 2017 to 2023.
The natural biomaterial segment is projected to grow at a significant CAGR during the forecast period.
Germany and France are the major shareholders, which collectively accounted for more than one-third share of the Europe bioimplant market in 2016.
Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific bioimplant market in 2016.

The North America market is projected to dominate the global bioimplant market in terms of revenue during the forecast period. This is majorly due to the increase in technological development and rise in incidence of cardiac, neuro, and spinal disorders. The Asia-Pacific market is expected to grow at the highest CAGR of 8.7% during the forecast period, owing to rise in awareness about the use of bio implants in the healthcare industry and surge in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs.

The major companies profiled in the report are Abbott Laboratories (St. Jude Medical, Inc.), Boston Scientific Corporation, Dentsply Sirona Inc., Johnson & Johnson (Ethicon, Inc.), Medtronic Plc, Smith & Nephew Plc, Stryker Corporation, Victrex Plc. (Invibio Ltd.), Wright Medical Group N.V., and Zimmer Biomet Holdings Inc.

Note: Product cover images may vary from those shown

5 of 4

Note: Product cover images may vary from those shown

License	Format	Properties	Price
SINGLE USER PDF	The product is a PDF.	This is a single user license, allowing one specific user access to the product.	€4867EUR$5,370USD£4,331GBP
1 - 5 USERS PDF	The product is a PDF.	This is a 1-5 user licence, allowing up to five users have access to the product.	€5845EUR$6,450USD£5,202GBP
ENTERPRISEWIDE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8152EUR$8,995USD£7,254GBP

PRODUCT CATEGORIES

RELATED TAGS

RELATED PRODUCTS

Biomaterials - A Global Market Overview

Collagen and HA-Based Biomaterials - Global Strategic Business Report

Global Bioimplants Market 2017-2021

Global Bio-implants Market - by Product Type, End User, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)

Bio-implants - Global Market Outlook (2017-2026)

YOUR QUESTION*

YOUR CONTACT DETAILS*